Neuren Pharmaceuticals Ltd
F:NK9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuren Pharmaceuticals Ltd
F:NK9
|
AU |
Wall St Price Targets
NK9 Price Targets Summary
Neuren Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for NK9 is 20.15 EUR with a low forecast of 15.83 EUR and a high forecast of 25.65 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NK9's stock price target?
Price Target
20.15
EUR
According to Wall Street analysts, the average 1-year price target for NK9 is 20.15 EUR with a low forecast of 15.83 EUR and a high forecast of 25.65 EUR.
What is the Revenue forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 38%.
What is the Operating Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
132%
The compound annual growth rate for Operating Income over the next 4 years is 132%.
What is the Net Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
117%
The compound annual growth rate for Net Income over the next 4 years is 117%.
